Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimmich

Showing results (271-280 of 331) with videos related to

Pageof 34
Sort By:
American Journal of Hematology|July 1, 2020
Localized immunoglobulin light chain amyloidosis: Novel insights including prognostic factors for local progressionMarco Basset, Kamal Hummedah, Christoph Kimmich, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 26, 2014
An evaluation of the role of environmental factors in the disease penetrance of cervical dystoniaAnna Molloy, Okka Kimmich, Laura Williams, et al.
Neurology|July 7, 2017
Sural nerve injury in familial amyloid polyneuropathy: MR neurography vs clinicopathologic toolsJennifer Kollmer, Felix Sahm, Ute Hegenbart, et al.
Brain, Behavior, and Immunity|March 11, 2023
Reduction in GABAB on glia induce Alzheimer's disease related changesAmanda M Leisgang Osse, Ravi S Pandey, Ryan A Wirt, et al.
European Journal of Midwifery|July 10, 2026
Potential benefits of applying the GebStart-tool for advising primiparous women during early labor: A comparative studySusanne Grylka-Baeschlin, Nadine Pauli, Catherine Rapp, et al.
Plos One|May 27, 2025
Development and preliminary validation of the GebStart-tool for advising nulliparous women in early labourSusanne Grylka-Baeschlin, Nadine Pauli, Catherine Rapp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2010
Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center studyGodehard Friedel, Wilfried Budach, Juergen Dippon, et al.
Haematologica|August 28, 2025
Extensive non-clonal CAR T-cell expansion causing fatal hyperinflammatory syndrome with immune effector cell-associated hemophagocytic lymphohistiocytosis, cytokine release syndrome, and neurotoxicity syndromeAndreas Riedel, Anna M P Stanger, Lucca M Kimmich, et al.
Blood|February 29, 2020
Daratumumab for systemic AL amyloidosis: prognostic factors and adverse outcome with nephrotic-range albuminuriaChristoph R Kimmich, Tobias Terzer, Axel Benner, et al.
Haematologica|May 20, 2017
Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: results of a prospective phase 2 study with long-term follow upUte Hegenbart, Tilmann Bochtler, Axel Benner, et al.
Pageof 34

Showing results (271-280 of 331) with videos related to

Sort By:
Pageof 34
American Journal of Hematology|July 1, 2020
Localized immunoglobulin light chain amyloidosis: Novel insights including prognostic factors for local progressionMarco Basset, Kamal Hummedah, Christoph Kimmich, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 26, 2014
An evaluation of the role of environmental factors in the disease penetrance of cervical dystoniaAnna Molloy, Okka Kimmich, Laura Williams, et al.
Neurology|July 7, 2017
Sural nerve injury in familial amyloid polyneuropathy: MR neurography vs clinicopathologic toolsJennifer Kollmer, Felix Sahm, Ute Hegenbart, et al.
Brain, Behavior, and Immunity|March 11, 2023
Reduction in GABAB on glia induce Alzheimer's disease related changesAmanda M Leisgang Osse, Ravi S Pandey, Ryan A Wirt, et al.
European Journal of Midwifery|July 10, 2026
Potential benefits of applying the GebStart-tool for advising primiparous women during early labor: A comparative studySusanne Grylka-Baeschlin, Nadine Pauli, Catherine Rapp, et al.
Plos One|May 27, 2025
Development and preliminary validation of the GebStart-tool for advising nulliparous women in early labourSusanne Grylka-Baeschlin, Nadine Pauli, Catherine Rapp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2010
Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center studyGodehard Friedel, Wilfried Budach, Juergen Dippon, et al.
Haematologica|August 28, 2025
Extensive non-clonal CAR T-cell expansion causing fatal hyperinflammatory syndrome with immune effector cell-associated hemophagocytic lymphohistiocytosis, cytokine release syndrome, and neurotoxicity syndromeAndreas Riedel, Anna M P Stanger, Lucca M Kimmich, et al.
Blood|February 29, 2020
Daratumumab for systemic AL amyloidosis: prognostic factors and adverse outcome with nephrotic-range albuminuriaChristoph R Kimmich, Tobias Terzer, Axel Benner, et al.
Haematologica|May 20, 2017
Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: results of a prospective phase 2 study with long-term follow upUte Hegenbart, Tilmann Bochtler, Axel Benner, et al.
Pageof 34